HIGHLIGHTS
- who: Darshana Patil and colleagues from the China Sapienza University of Rome, Italy have published the research work: Multi-analyte liquid biopsies for molecular pathway guided personalized treatment selection in advanced refractory cancers: A clinical utility pilot study, in the Journal: (JOURNAL)
- what: Patients and methods: LIQUID IMPACT was a pilot clinical study where patients with advanced refractory cancers received combination anticancer treatment regimens based on multi-analyte liquid biopsy (MLB) profiling of circulating tumor biomarkers; this study design was based on the findings of prior feasibility analysis to determine the abundance of targetable variants . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.